You are here

Immunity DOI:10.1016/j.immuni.2021.03.016

Splice it up: Atypical transcripts to boost leukemia immunotherapy.

Publication TypeJournal Article
Year of Publication2021
AuthorsCieri, N, Wu, CJ
JournalImmunity
Volume54
Issue4
Pages608-610
Date Published2021 Apr 13
ISSN1097-4180
Abstract

Neoantigens are prime targets for cancer immunotherapy, but their identification in low mutational burden malignancies remains challenging. In this issue of Immunity, Ehx et al. show that atypical transcripts, and particularly retained introns, expand the spectrum of leukemia immunotherapy targets.

DOI10.1016/j.immuni.2021.03.016
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/33852826?dopt=Abstract

Alternate JournalImmunity
PubMed ID33852826